Aeterna Zentaris to Present at Upcoming Canaccord Genuity 34th Annual Global Growth Conference in Boston

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\nQUÉBEC CITY, Aug. 6, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that the Company's\n Chairman, CEO, David Dodd, will be presenting a corporate overview at\n the Canaccord Genuity 34th Annual Global Growth Conference on\n Wednesday, August 13, 2014, at 1pm (Eastern), in the Melbourne Room of\n the Intercontinental Hotel in Boston.\n\n\nA live audio and slide webcast of the presentation will be available via\n the Company's website at www.aezsinc.com in the \"Newsroom\" section, under \"Events and Webcasts\". A replay of the\n webcast will also be available on the Company's website for a period of\n 90 days.\n\n\nAbout Aeterna Zentaris Inc.\n\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in\n developing and commercializing novel treatments in oncology and\n endocrinology. The Company's pipeline encompasses compounds at various\n stages of development. For more information, visit www.aezsinc.com.\n\n\nSOURCE Aeterna Zentaris Inc.\n\n\n\n Paul Burroughs Director of Communications (418) 652-8525 ext. 406 [email protected] Copyright CNW Group 2014","length":1825,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.